Latest News & Features
Americas
Ahead of the upcoming LSPN North America-Spring 2025 conference, chair Eldora Ellison shares insights on emerging innovations in AI and gene editing, and offers advice for thriving in a competitive environment. 8 April 2025
Europe
The court hands Edwards Lifesciences a win in its long-running battle with Meril | Panel issues a second Europe-wide injunction over prosthetic heart valve technology | Judges reject Meril’s latest attempt to invalidate Edwards’ patent. 8 April 2025
Careers
Miami-based hire brings experience in patent litigation and portfolio management, having previously worked on drug cases involving Lialda, Vyvanse, and Intuniv, among others. 7 April 2025
Americas
The IP specialist bypassed vendors and turned to its own ‘tech geeks’ to create an in-house AI solution for drafting patent applications. LSIPR meets the attorney coders doing it for themselves. 3 April 2025
Europe
The pressures of IP law can take a serious toll on mental wellbeing. Boult Wade Tennant partner and WIPR Diversity Champion, Susi Fish, shares her experiences and tips for managing stress. 3 April 2025
Americas
Lawsuits against pharmacies in seven states aim to protect its flagship Mounjaro and Zepbound medications | Growing competition and patent expiration increase urgency for Lilly | New Jersey and Delaware stores accused of selling unapproved tirzepatide-based products. 3 April 2025
Americas
MSD, Novartis and Eli Lilly are among those whose multi-billion-dollar patents are hurtling towards expiration, writes Marisa Woutersen. 1 April 2025
Careers
Leading patent litigator who worked on disputes involving Broadcom, Sonos, and Tesla joins firm’s Düsseldorf office from EIP. 1 April 2025
Europe
With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster blood thinner from generics. Marisa Woutersen finds Bayer’s outside litigation counsel ready for anything. 31 March 2025
Americas
Both parties write to district court hours after Court of Appeals denies rehearing | MSN maintains that the Entresto patent should be delisted from the Orange Book | Novartis urges injunction to block generic version of heart treatment before regulatory gap closes. 27 March 2025